Graph database services are divided into managed services and professional services, targeting different stages of implementation and operation. Managed services include end-to-end management of graph ...
Abstract: Since the introduction of ChatGPT, large language models (LLMs) have demonstrated significant utility in various tasks, such as answering questions through retrieval-augmented generation.
This week, we are excited to kick off SQLCon 2026 alongside FabCon in Atlanta. Bringing these SQL and Fabric communities together creates a unique opportunity to learn, connect, and share what’s next ...
In this digital age, organizing and managing data efficiently is crucial. Whether you are keeping records on people, products, livestock, and/or fields, managing projects, or planning events, having a ...
SQLite has its place, but it’s not fit for every occasion. Learn how to set up install-free versions of MariaDB, PostgreSQL MongoDB, and Redis for your development needs. For any application that ...
A new AI infrastructure platform claims to let enterprises deploy artificial intelligence without exposing raw or regulated data, a long-standing challenge for organizations operating under strict ...
Another year passes. I was hoping to write more articles instead of just these end-of-the-year screeds, but I almost died in the spring semester, and it sucked up my time. Nevertheless, I will go ...
TL;DR: KIOXIA's open-source AiSAQ technology reduces DRAM needs by offloading vectorized AI data to SSDs, enabling scalable, low-latency Retrieval Augmented Generation (RAG) pipelines. Its integration ...
'We see 2026 as the year that investors begin to shift their focus from hardware to software positions,' an HSBC analyst writes Oracle's vectorized database will prove to be a key advantage as the AI ...
AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) ...
VectorY Therapeutics has seen the shape of things to come—and it involves finding fresh ways to deliver its gene therapies into the brain. The Dutch biotech has secured an exclusive option to evaluate ...